1. Home
  2. JSPR vs DSM Comparison

JSPR vs DSM Comparison

Compare JSPR & DSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JSPR
  • DSM
  • Stock Information
  • Founded
  • JSPR 2018
  • DSM 1989
  • Country
  • JSPR United States
  • DSM United States
  • Employees
  • JSPR N/A
  • DSM N/A
  • Industry
  • JSPR Biotechnology: Biological Products (No Diagnostic Substances)
  • DSM Investment Managers
  • Sector
  • JSPR Health Care
  • DSM Finance
  • Exchange
  • JSPR Nasdaq
  • DSM Nasdaq
  • Market Cap
  • JSPR 342.2M
  • DSM 303.5M
  • IPO Year
  • JSPR N/A
  • DSM N/A
  • Fundamental
  • Price
  • JSPR $23.09
  • DSM $6.17
  • Analyst Decision
  • JSPR Strong Buy
  • DSM
  • Analyst Count
  • JSPR 10
  • DSM 0
  • Target Price
  • JSPR $74.86
  • DSM N/A
  • AVG Volume (30 Days)
  • JSPR 214.2K
  • DSM 161.7K
  • Earning Date
  • JSPR 11-07-2024
  • DSM 01-01-0001
  • Dividend Yield
  • JSPR N/A
  • DSM 3.97%
  • EPS Growth
  • JSPR N/A
  • DSM N/A
  • EPS
  • JSPR N/A
  • DSM N/A
  • Revenue
  • JSPR N/A
  • DSM N/A
  • Revenue This Year
  • JSPR N/A
  • DSM N/A
  • Revenue Next Year
  • JSPR N/A
  • DSM N/A
  • P/E Ratio
  • JSPR N/A
  • DSM N/A
  • Revenue Growth
  • JSPR N/A
  • DSM N/A
  • 52 Week Low
  • JSPR $4.00
  • DSM $4.69
  • 52 Week High
  • JSPR $31.01
  • DSM $6.05
  • Technical
  • Relative Strength Index (RSI)
  • JSPR 56.05
  • DSM 61.17
  • Support Level
  • JSPR $22.30
  • DSM $6.09
  • Resistance Level
  • JSPR $26.05
  • DSM $6.18
  • Average True Range (ATR)
  • JSPR 1.65
  • DSM 0.05
  • MACD
  • JSPR 0.05
  • DSM 0.02
  • Stochastic Oscillator
  • JSPR 57.29
  • DSM 93.48

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

About DSM BNY Mellon Strategic Municipal Bond Fund Inc.

BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.

Share on Social Networks: